| Tue, Feb 9, 2010 |
| • |
Biotech Stocks: Cell Therapeutics, AstraZeneca lead drug stocks
at MarketWatch (Tue 1:31pm)
|
| • |
BioMarin to Expand, Offers Guidance
Zacks.com (Tue 11:13am)
|
| • |
Biotech Stocks: Drug stocks gain; Cell Therapeutics rebounds
at MarketWatch (Tue 10:23am)
|
| • |
Caterpillar: Analysts' Upgrades, Downgrades
at TheStreet.com (Tue 9:33am)
|
| • |
Biomarin Pharm upgraded by Roth Capital
Briefing.com (Tue 2:03am)
|
| Mon, Feb 8, 2010 |
| • |
CVS Caremark, Motorola, Hasbro are big movers
AP (Mon, Feb 8)
|
| • |
Biotech Stocks: Drug stocks turn higher; Cell Therapeutics tumbles
at MarketWatch (Mon, Feb 8)
|
| • |
BioMarin shares fall, Brean analyst downgrades
AP (Mon, Feb 8)
|
| • |
Biotech Stocks: BioMarin, Cell Therapeutics lead drug stocks south
at MarketWatch (Mon, Feb 8)
|
| • |
China Biotech Week in Review: New Investments in Life Science
at Seeking Alpha (Mon, Feb 8)
|
| Fri, Feb 5, 2010 |
| • |
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri, Feb 5)
|
| • |
BioMarin to buy LEAD for $97M, gives 2010 outlook
AP (Fri, Feb 5)
|
| Thu, Feb 4, 2010 |
| • |
BioMarin to buy Lead Therapeutics for $18M
at bizjournals.com (Thu, Feb 4)
|
| • |
Stocks Outlook: Small Caps Still Have Way to Go Higher
at CNBC (Thu, Feb 4)
|
| • |
BioMarin Announces 2010 Guidance
PRNewswire (Thu, Feb 4)
|
| • |
BioMarin to Acquire LEAD Therapeutics
PRNewswire (Thu, Feb 4)
|
| • |
BioMarin Reports Encouraging Preliminary Data on BMN 110 for MPS IVA
PRNewswire (Thu, Feb 4)
|
| Tue, Feb 2, 2010 |
| • |
BioMarin to Host Fourth Quarter and Full Year 2009 Financial Results Conference Call and Webcast on Tuesday, February 23 at 5:00 p.m. ET
PRNewswire (Tue, Feb 2)
|
| • |
BioMarin to Present at the BIO CEO and Investor Conference
PRNewswire (Tue, Feb 2)
|
| Wed, Jan 27, 2010 |
| • |
67% Decline In Consumable Cost For Human Genome Sequencing Seen In 2010 By First Analysis Equity Valuation Expert
Wall Street Transcript (Wed, Jan 27)
|
| Older Headlines |
|
|
|
|
Help
Headlines
